Residual Volume Reversibility Is a Better Test in Identifying Reversible Airway Disease Compared to FEV1 Reversibility in Patients With Chronic Persistent Asthma.

Sasan Sazgar, Ali Rashidian, Belayneh Abejie, Vipul Jain, Jose Vempilly. Residual Volume Reversibility Is a Better Test in Identifying Reversible Airway Disease Compared to FEV1 Reversibility in Patients With Chronic Persistent Asthma. CHEST Journal. 2016 Oct 1; 150(4):919a.

2016
https://researcherprofiles.org/profile/79294339

Sasan Sazgar, Ali Rashidian, Belayneh Abejie, Vipul Jain, Jose Vempilly